Alphabet: Analyst Consensus Points To Q2 Revenues Of $69.95 Billion

Alphabet (NASDAQ: GOOGL) will be reporting its second quarter financial results on July 26th after market close. Analysts have a consensus $153.83 12-month price target on the company, via a total of 50 analysts, with 15 analysts having strong buy ratings. 32 analysts meanwhile have buy ratings and three analysts have hold ratings. The street high comes from Elazar Advisors with a $226.67 price target, and the lowest target sits at $118.

31 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 31 analysts is $69.95 billion; this number has been slightly revised downwards since the start of the year. The highest revenue estimate is $72.1 billion, while the lowest is $66.85 billion.

Onto EBITDA estimates, there are currently 25 analysts who have second-quarter EBITDA estimates. The mean is currently $28.55 billion. The estimate has been revised lower since the start of the year. Street high is a $30.68 billion EBITDA estimate, and the lowest is $26.9 billion.

Analysts estimate that quarterly earnings per share will come in at $1.29, slightly down from the $1.34 estimate at the start of the year. The street high estimate is $1.54 and the lowest estimate is $1.12 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

How to Still Find 10-Bagger Gold and Silver Stocks | Don Durrett

First Majestic Silver: Jerritt Canyon Is BACK!

Canada May Finally Be Backing Its Battery Supply Chain | John Passalacqua – First Phosphate

Recommended

Silver47 Pulls High-Grade Gold and Silver Assays from Nevada Vein Network At Kennedy

Canadian Gold Resources Taps Chernin as Interim CEO in Planned Transition

Related News

Ascend Wellness: Canaccord Initiates With US$15 Price Target

Canaccord Genuity is the first investment bank to initiate coverage on Ascend Wellness (CSE: AAWH.u)....

Tuesday, May 25, 2021, 03:12:00 PM

Eldorado Gold: Analyst Ratings Unchanged Despite Production Beats

Eldorado Gold (TSX: ELD) released their Q2’20 preliminary results earlier this week, which included production...

Saturday, July 11, 2020, 08:30:00 AM

Antibe Therapeutics: Canaccord Upgrades Price Target To $16.50

Earlier this week, Antibe Therapeutics (TSXV: ATE) announced a strategic licensing deal with Nuance Pharm...

Thursday, February 11, 2021, 04:07:00 PM

Tilray: Canaccord Cuts Price Target To $9.00

On January 10th, Tilray Inc (TSX: TLRY) reported their fiscal second-quarter financial results, the company...

Tuesday, January 11, 2022, 04:22:00 PM

NG Energy: Beacon Maintains $2.80 Price Target After Sinu-9 Discovery

Yesterday, NG Energy (TSXV: GASX) announced that it had conducted two successful drillstem tests and...

Wednesday, August 3, 2022, 04:29:00 PM